Healthcare Industry News: Intra-operative Imaging
News Release - October 27, 2009
Medtronic Launches New Neuro Oncology Surgical Imaging System InternationallyPoleStar(R) N30 Surgical MRI for Neurosurgery Designed to Optimize Tumor Resection Procedures
MINNEAPOLIS--(HSMN NewsFeed)--This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT ) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions. The PoleStar N30 System has been submitted to the U.S. Food and Drug Administration for approval.
Providing real-time imaging in the operating room (OR), the PoleStar Surgical MRI provides surgeons with targeting and navigational accuracy despite the anatomy movement that may occur during a procedure. With Intra-operative Imaging information, neurosurgeons have more confidence to achieve maximum tumor resection, while avoiding critical areas of the brain. Use of the PoleStar system may also reduce the need for revision surgeries and the length of stay at the hospital for the patient.
“This is the next generation of intra-operative MRI providing flexibility, enhanced ergonomics and confidence in the achievement of surgical goals,” said Jim Cloar, vice president and general manager of the Navigation division, part of the Surgical Technologies business at Medtronic. “With its unique compact design, the PoleStar Surgical MRI system allows neurosurgeons to benefit from intra-operative MR imaging without the compromises inherent in other systems, such as extensive renovation of the operating room or restrictions upon the surgeons' choice of instruments.”
Dr. Moshe Hadani, Chairman of Neurosurgery, Sheba Medical Center in Israel was a frequent user of the previous model of the PoleStar Surgical MRI. “Recently we installed the PoleStar N30 System. We have found the new PoleStar to have great improvements in ergonomics. The scanner is smaller, easier to handle and it fits better into the OR environment. Using the PoleStar, I have great confidence in the extent of tumor resection prior to closing.”
More than 50 PoleStar systems have been installed in ORs worldwide since 2001. The launch of the PoleStar N30 is the culmination of six years of research and development by Medtronic scientists and engineers working with surgeon customers from leading hospitals and clinics.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 24, 2009. Actual results may differ materially from anticipated results.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsMedtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense(TM) Data in Rune's Software for Precision Neurology
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business